Curis
CRIS
#11190
Rank
HK$12.77 M
Marketcap
HK$5.27
Share price
-5.38%
Change (1 day)
-57.96%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -HK$112.35

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$111.59. In 2025 the company made an earnings per share (EPS) of -HK$186.84 an increase over its 2024 EPS that were of -HK$1,103.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$112.35-39.87%
2025-HK$186.84-83.07%
2024-HK$1,103-22.15%
2023-HK$1,417-26.17%
2022-HK$1,91922.3%
2021-HK$1,569-25.37%
2020-HK$2,103-30.93%
2019-HK$3,045-2.02%
2018-HK$3,107
2016-HK$7,062-10%
2015-HK$7,847138.1%
2014-HK$3,29640%
2013-HK$2,354-25%
2012-HK$3,13966.67%
2011-HK$1,883

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.63-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$25.90-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.14-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$24.95-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$26.99-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA